Migraine
Not recruitingStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
- Disease:Migraine
- Substances:Lu Ag09222
Lithuania- Participants:18–64 years
- Substances:Lu Ag09222
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Lithuania1 clinical trial in Taurage, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
LithuaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on migraine prevention is underway, specifically targeting patients who haven't responded well to existing preventative treatments.
The study aims to evaluate new therapeutic approaches for individuals dealing with persistent migraines, representing an important advancement in neurological treatment options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.